Showing items 1 - 5 of 5

Your selections:

Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT

- Zhou, K., Renouf, M., Catton, C., Bellanger, M., Supiot, S., Perrocheau, G., Magné, N., Latorzeff, I., Pommier, P., Créhange, G., Paumier, A., Bera, G., Martin, J.

Population-Level Uptake of Moderately Hypofractionated Definitive Radiation Therapy in the Treatment of Prostate Cancer

- Nithiyananthan, Kajanan, Creighton, Nicola, Currow, David, Martin, Jarad M.

Adoption of hypofractionated radiation therapy for early breast cancer in private practice: the GenesisCare experience 2014–2106

- Neville, Katherine, Dreosti, Marcus, Blakey, David, Latham, Margaret, Izard, Michael A., Young, Susan, Graham, Georgia, O’Brien, Peter

Moderate hypofractionation for prostate cancer: A user's guide

- Pryor, David I., Turner, Sandra L., Tai, Keen Hun, Tang, Colin, Sasso, Giuseppe, Dreosti, Marcus, Woo, Henry H., Wilton, Lee, Martin, Jarad M.

Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy

- Sethukavalan, Perakaa, Cheung, Patrick, Tang, Colin I., Quon, Harvey, Morton, Gerard, Nam, Robert, Loblaw, D. Andrew

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit